Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphoma

The past two decades of lymphoma research have uncovered the essential role of the B-cell antigen receptor (BCR) pathway in lymphoma biology. This resulted in the development of targeted inhibitors for the treatment of several B-cell malignancies, especially chronic lymphocytic leukemia (CLL)